EULAR Task Forces
It is EULAR's objective to promote task forces aimed at elaborating recommendations in the field of rheumatology with adherence to the principles of equality, diversity and inclusion.
The members of EULAR task forces are experienced investigators in Rheumatology with areas of focus such as Quality of Care and Clinical Affairs (QoC), Research (RES), Health Professionals in Rheumatology (HPR), and PARE People with Arthritis and Rheumatism (PARE).
Each task force is connected to and supported by a EULAR Committee. Each committee is entitled to apply for EULAR endorsement, and also apply for EULAR task force members (see related information).
To apply as task force member please go to the project dedicated application’s links below:
Open initiatives
The EULAR wide general application call for 5 additional slots in the recently funded Task Forces projects is now open for the submissions of EULAR national organizations’ members.
The deadline to apply is by 30 April 23.45 hrs CEST
New projects below:
QoC033-Update of the EULAR Recommendations for Cardiovascular Risk Management in Patients with Rheumatic and Musculoskeletal Diseases, - Mike Nurmohamed-Maria Tektonidou
QoC032-EULAR recommendations for the assessment of malignancy risk in autoimmune rheumatic diseases, - Elena Nikiphorou
QoC031-EULAR points to consider on the combination of targeted therapies in patients with inflammatory arthritis or systemic autoimmune rheumatic diseases, - Jacques Eric Gottenberg
QoC030-202X update of the EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors, - Hendrik Schulze-Koops
Related Information
Application for Project Grants
EULAR welcomes project applications from rheumatologists across Europe designed for developing EULAR Recommendations, EULAR Criteria, EULAR Points to Consider, or similar projects.
EULAR Recommendations
The EULAR Committees regularly establish and publish recommendations for the treatment of various rheumatic disorders. Each of these recommendations are developed by a Task Force of specialists in their field.